Welcome to our dedicated page for ESAB news (Ticker: ESAB), a resource for investors and traders seeking the latest updates and insights on ESAB stock.
ESAB Corporation reports company news tied to its industrial equipment and consumables business for welding, cutting and joining applications. Updates include operating and financial results, dividend declarations, capital-structure actions, and governance changes at the public-company level.
Company announcements also cover product and portfolio developments within ESAB-backed gas control businesses, including GCE Specialty, GCE Medical and GCE Industrial equipment for specialty, medical and industrial applications.
ESAB (NYSE: ESAB) has announced its upcoming first quarter 2025 earnings release and conference call schedule. The company will release financial results on Thursday, May 1, 2025, followed by a conference call at 8:00 a.m. Eastern.
Investors and stakeholders can participate in the conference call through:
- U.S. callers: +1-888-550-5302
- International callers: +1-646-960-0685
- Conference ID: 4669992
The earnings release and supplemental materials will be available on the company's website under the 'Investors' section. Founded in 1904, ESAB is a premier industrial compounder employing approximately 9,300 associates and serving customers in about 150 countries from its North Bethesda, Maryland headquarters.
ESAB (NYSE: ESAB), a focused premier industrial compounder founded in 1904, has announced its Board of Directors' declaration of a quarterly cash dividend of $0.08 per share of common stock. The dividend will be paid on April 17, 2025, to shareholders of record as of April 4, 2025.
The company, headquartered in North Bethesda, Maryland, employs approximately 9,300 associates and serves customers in about 150 countries. ESAB's operations are supported by their innovative products, workflow solutions, and business system ESAB Business Excellence.
ESAB reported Q4 2024 sales of $671 million, showing flat core organic growth but a 3% decrease on a reported basis compared to the previous year. The company achieved net income from continuing operations of $72 million, or $1.18 diluted earnings per share, with core adjusted net income of $79 million ($1.28 per share).
Core adjusted EBITDA reached $129 million, rising 2% with margins expanding 90 basis points to 20.3%. The company completed the acquisition of SUMIG in Q4 2024 and announced an agreement to acquire Bavaria Schweisstechnik GmbH. For 2025, ESAB projects core organic growth of 0.0% to 2.0% and total core sales growth of -2.0% to 0.0%, factoring in -3.5% currency headwinds and 1.5% M&A growth. The company expects core adjusted EBITDA of $515-530 million and core adjusted EPS of $5.10-5.25 for 2025.
ESAB (NYSE: ESAB) has announced it will release its fourth quarter 2024 financial results on Thursday, February 20, 2025, followed by a conference call at 8:00 a.m. Eastern. The conference call will be accessible to U.S. callers at +1-888-550-5302 and international callers at +1-646-960-0685 using conference ID 4669992.
The financial results and any supplemental information will be available on ESAB's website under the 'Investors' section. A replay of the call will also be made available on the website. Founded in 1904, ESAB is a premier industrial compounder employing approximately 9,000 associates and serving customers in about 150 countries from its North Bethesda, Maryland base.
ESAB (NYSE: ESAB) announced that its Board of Directors has declared a quarterly cash dividend of $0.08 per share of common stock. The dividend will be paid on January 17, 2025, to shareholders of record as of December 31, 2024. ESAB, founded in 1904, is a premier industrial compounder employing approximately 9,000 associates and serving customers in about 150 countries from its North Bethesda, Maryland headquarters.
Over 150 plaintiffs have filed a lawsuit against Cape PLC, its subsidiaries and affiliates including Anglo American, De Beer Group, and ESAB Corp for importing and distributing carcinogenic asbestos in the United States. The lawsuit alleges that Cape, which sold more than 95% of asbestos used in industry and U.S. Navy ships, concealed known health risks and created complex corporate structures to avoid liability. The case includes plaintiffs suffering from mesothelioma and lung cancer, as well as families of deceased victims. A South Carolina court has appointed a receiver after the companies and insurers failed to respond to previous lawsuits.
ESAB reported Q3 2024 sales of $673 million, showing a 1% decrease on a reported basis but a 1% increase in core organic growth. The company achieved net income of $69 million ($1.13 per share) and core adjusted net income of $77 million ($1.25 per share). Core adjusted EBITDA reached $125 million, up 6% with margin expanding 130 basis points to 19.6%. ESAB updated its 2024 outlook, now expecting full-year core organic sales growth of 0.0% to 1.0%, with core adjusted EBITDA projected at $500-515 million and core adjusted EPS of $4.80-4.95.
A South Carolina court has set a trial date of Feb. 3, 2025, to determine if Anglo-American, PLC (OTCQX: NGLOY), ESAB Corp. (NYSE: ESAB), and billionaire Mohed Altrad are responsible for billions in asbestos liabilities. The case stems from Cape Asbestos' distribution of asbestos to U.S. companies. A court-appointed receiver filed suit in June 2023 against these entities for unjust enrichment and responsibility for Cape's actions. ESAB is alleged to be the ultimate parent company of entities controlling Cape, while Anglo American owns 85% of De Beers. Mohed Altrad, convicted of bribery in France, is identified as Cape's current majority shareholder through Altrad Group. The case highlights decades of alleged avoidance of harm caused by Cape's asbestos, which is known to cause fatal cancers.
ESAB (NYSE: ESAB) has announced its schedule for the third quarter 2024 earnings release and conference call. The company will issue a press release with financial results on the morning of Tuesday, October 29, 2024. A conference call to discuss these results will be held at 8:00 a.m. Eastern on the same day.
The call will be accessible to the public via phone and webcast through ESAB's website. U.S. callers can dial +1-888-550-5302, while international callers should use +1-646-960-0685, referencing the conference ID number 4669992. The financial results press release and any supplemental information will be available on ESAB's website prior to the call. A replay link will also be provided on the website later that day.